213
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Time Trends in Incidence of Reported Memory Concerns and Cognitive Decline: A Cohort Study in UK Primary Care

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 395-408 | Published online: 24 Mar 2022

References

  • World Health Organisation. Dementia World Health Organisation. World Health Organisation; 2020 [ updated September 21, 2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed February 25, 2022.
  • Alzheimer’s Society. The dementia guide: living well after diagnosis. Alzheimer’s Society; 2017. Available from: https://www.alzheimers.org.uk/sites/default/files/pdf/the_dementia_guide.pdf. Accessed February 25, 2022.
  • Department of Health. Living well with dementia: a national dementia strategy. Department of Health; 2009.
  • World Health Organisation. Global status report on the public health response to dementia; 2021. Available from: https://www.who.int/publications/i/item/9789240033245. Accessed February 25, 2022.
  • Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006;367(9518):1262–1270. doi:10.1016/S0140-6736(06)68542-5
  • Montejo P, Montenegro M, Fernández MA, et al. Subjective memory complaints in the elderly: prevalence and influence of temporal orientation, depression and quality of life in a population-based study in the city of Madrid. Aging Ment Health. 2011;15(1):85–96. doi:10.1080/13607863.2010.501062
  • Luck T, Roehr S, Rodriguez FS, et al. Memory-related subjective cognitive symptoms in the adult population: prevalence and associated factors–results of the LIFE-Adult-Study. BMC Psychol. 2018;6(1):23. doi:10.1186/s40359-018-0236-1
  • Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29(4):753–772. doi:10.1016/j.cger.2013.07.003
  • Overton M, Pihlsgård M, Elmståhl S. Prevalence and incidence of Mild Cognitive Impairment across subtypes, age, and sex. Dement Geriatr Cogn Disord. 2019;47(4–6):219–232. doi:10.1159/000499763
  • Mitchell AJ. The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and dementia: a meta‐analysis. Int J Geriatr Psychiatry. 2008;23(11):1191–1202. doi:10.1002/gps.2053
  • Mitchell A, Beaumont H, Ferguson D, et al. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta‐analysis. Acta Psychiatr Scand. 2014;130(6):439–451. doi:10.1111/acps.12336
  • Juncos‐Rabadán O, Pereiro AX, Facal D, et al. Prevalence and correlates of mild cognitive impairment in adults aged over 50 years with subjective cognitive complaints in primary care centers. Geriatr Gerontol Int. 2014;14(3):667–673. doi:10.1111/ggi.12157
  • Bohlken J, Kostev K. Coded prevalence of mild cognitive impairment in general and neuropsychiatrists practices in Germany between 2007 and 2017. J Alzheimer’s Dis. 2019;67(4):1313–1318. doi:10.3233/JAD-181180
  • Hallam B, Rees J, Petersen I, et al. How are people with mild cognitive impairment or subjective memory complaints managed in primary care? A systematic review. Fam Pract. 2021;38(5):669–683. doi:10.1093/fampra/cmab014
  • Elm E, Altman D, Egger M, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806–808. doi:10.1136/bmj.39335.541782.AD
  • Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18(1):76–83. doi:10.1002/pds.1688
  • Horsfall L, Walters K, Petersen I. Identifying periods of acceptable computer usage in primary care research databases. Pharmacoepidemiol Drug Saf. 2013;22(1):64–69. doi:10.1002/pds.3368
  • Blak B, Thompson M, Dattani H, et al. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. J Innov Health Inform. 2011;19(4):251–255. doi:10.14236/jhi.v19i4.820
  • Statistics OfN. 2011 Census Data; 2011. Available from: https://www.ons.gov.uk/census/2011census/2011censusdata. Accessed February 25, 2022.
  • Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. Routledge; 1988.
  • Chisholm J. The Read clinical classification. Br Med J. 1990;300(6732):1092. doi:10.1136/bmj.300.6732.1092
  • Davé S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf. 2009;18(8):704–707. doi:10.1002/pds.1770
  • Lewis JD, Bilker WB, Weinstein RB, et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf. 2005;14(7):443–451. doi:10.1002/pds.1115
  • Carreira H, Williams R, Strongman H, et al. Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review. BMJ open. 2019;9(7):e029227. doi:10.1136/bmjopen-2019-029227
  • Whitty E, Mansour H, Aguirre E, et al. Efficacy of lifestyle and psychosocial interventions in reducing cognitive decline in older people: systematic review. Ageing Res Rev. 2020;62:101113. doi:10.1016/j.arr.2020.101113
  • Iliffe S, Wilcock J. The UK experience of promoting dementia recognition and management in primary care. Z Gerontol Geriatr. 2017;50(Suppl 2):63–67. doi:10.1007/s00391-016-1175-1
  • Liu D, Green E, Kasteridis P, et al. Incentive schemes to increase dementia diagnoses in primary care in England: a retrospective cohort study of unintended consequences. Br J Gen Pract. 2019;69(680):e154–e163. doi:10.3399/bjgp19X701513
  • Richardson C, Stephan BC, Robinson L, et al. Two-decade change in prevalence of cognitive impairment in the UK. Eur J Epidemiol. 2019;34(11):1085–1092. doi:10.1007/s10654-019-00554-x
  • Wolters FJ, Chibnik LB, Waziry R, et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer Cohorts Consortium. Neurology. 2020;95(5):e519–e31. doi:10.1212/WNL.0000000000010022
  • Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–2263. doi:10.1016/S0140-6736(15)60461-5
  • Poppe M, Mansour H, Rapaport P, et al. “Falling through the cracks”; Stakeholders’ views around the concept and diagnosis of mild cognitive impairment and their understanding of dementia prevention. Int J Geriatr Psychiatry. 2020;35(11):1349–1357. doi:10.1002/gps.5373
  • Bohlken J, von Stillfried D, Schulz M. Prevalence rates of mild cognitive impairment and of dementia in the German outpatient health care sector 2009–2016. Psychiatr Prax. 2019;47(1):16–21. doi:10.1055/a-1012-9502
  • Röhr S, Pabst A, Riedel-Heller SG, et al. Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study. Alzheimer’s Res Ther. 2020;12(1):1–14.
  • Russell P, Banerjee S, Watt J, et al. Improving the identification of people with dementia in primary care: evaluation of the impact of primary care dementia coding guidance on identified prevalence. BMJ open. 2013;3:12. doi:10.1136/bmjopen-2013-004023
  • McGuinness LA, Warren‐Gash C, Moorhouse LR, et al. The validity of dementia diagnoses in routinely collected electronic health records in the United Kingdom: a systematic review. Pharmacoepidemiol Drug Saf. 2019;28(2):244–255. doi:10.1002/pds.4669